Literature DB >> 10524955

Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group.

S Cu-Uvin1, J W Hogan, D Warren, R S Klein, J Peipert, P Schuman, S Holmberg, J Anderson, E Schoenbaum, D Vlahov, K H Mayer.   

Abstract

This study was undertaken to assess whether the prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive women was higher than among high-risk HIV-seronegative women at their baseline visit for the HIV Epidemiology Research Study. Results were available for 851 HIV-seropositive and 434 HIV-seronegative women. Human papilloma virus (HPV) infection was more prevalent among HIV-seropositive women (64% vs. 28%). Bacterial vaginosis was common (35% vs. 33%), followed by trichomoniasis (12% vs. 10%), syphilis (8% vs. 6%), Chlamydia trachomatis infection (4% vs. 5%), candidal vaginitis (3% vs. 2%), and Neisseria gonorrhoeae infection (0.8% vs. 0.3%). Alcohol use (odds ratio [OR], 1.8; 95% confidence interval [CI], 1. 3-2.4) and smoking (OR, 1.8; 95% CI, 1.3-2.5) were associated with bacterial vaginosis. Bacterial vaginosis (OR, 2.3; 95% CI, 1.5-3.4), trichomoniasis (OR, 2.3; 95% CI, 1.1-4.7), and syphilis (OR, 3.1; 95% CI, 1.3-7.4) were found to be more prevalent among black women. Our study showed no statistically significant difference in the prevalence of lower genital tract infections except for HPV between HIV-infected and demographically and behaviorally similar HIV-uninfected high-risk women.

Entities:  

Mesh:

Year:  1999        PMID: 10524955     DOI: 10.1086/313434

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.

Authors:  Megan Gatski; Leandro Mena; Judy Levison; Rebecca A Clark; Harold Henderson; Norine Schmidt; Susan L Rosenthal; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2010-08       Impact factor: 2.830

Review 2.  Care of the human immunodeficiency virus-infected menopausal woman.

Authors:  Helen Elizabeth Cejtin
Journal:  Am J Obstet Gynecol       Date:  2011-12-30       Impact factor: 8.661

Review 3.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

4.  New variants of human papillomavirus type 18 identified in central Brazil.

Authors:  Daniela Marreco Cerqueira; Tainá Raiol; Nazle Mendonça Collaço Véras; Natália von Gal Milanezi; Fádia Aguiar Amaral; Marcelo de Macedo Brígido; Cláudia Renata Fernandes Martins
Journal:  Virus Genes       Date:  2008-07-29       Impact factor: 2.332

Review 5.  Vaginal microbiota and susceptibility to HIV.

Authors:  McKenna C Eastment; R Scott McClelland
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

Review 6.  Trichomonas vaginalis, HIV, and African-Americans.

Authors:  F Sorvillo; L Smith; P Kerndt; L Ash
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

7.  Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study.

Authors:  Carla Moreira; Kartik K Venkatesh; Allison DeLong; Tao Liu; Jaclyn Kurpewski; Jessica Ingersoll; Angela M Caliendo; Susan Cu-Uvin
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

8.  Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.

Authors:  Kenneth H Fife; Julia W Wu; Kathleen E Squires; D Heather Watts; Janet W Andersen; Darron R Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

9.  CD57 expression by T cells in the female genital tract of HIV-zx1 infected women.

Authors:  Lenine J Liebenberg; Adebayo Lawrence Adedeji; Darren P Martin; Pam P Gumbi; Lynette Denny; Jo-Ann S Passmore
Journal:  Clin Immunol       Date:  2010-01-25       Impact factor: 3.969

10.  Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis.

Authors:  Caroline Mitchell; Carla Moreira; David Fredricks; Kathleen Paul; Angela M Caliendo; Jaclynn Kurpewski; Jessica Ingersoll; Susan Cu-Uvin
Journal:  Infect Dis Obstet Gynecol       Date:  2009-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.